An analytical method for detecting related substances in dihydropyridine compounds.
By employing liquid chromatography-mass spectrometry (LC-MS) combined with ninhydrin derivatization, we have achieved precise detection of β-aminocrotonate in dihydropyridine calcium channel blockers, solving the detection challenges in existing technologies and ensuring that drug quality meets ICH standards.
Patent Information
- Application Number
- CN202512014856.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-12-30
- Filing Date
- 2025-12-30
- Publication Date
- 2026-06-30
AI Technical Summary
Existing technologies make it difficult to accurately detect the content of β-aminocrotonate in dihydropyridine calcium channel blockers, especially impurities in its unsaturated ketone structure, which affects drug quality and patient health.
A liquid chromatography-mass spectrometry (LC-MS) method was used to detect the content of compound I in dihydropyridine compounds by adding ninhydrin to the solution of dihydropyridine compounds. The specific steps included using an octadecylsilane-bonded silica column and gradient elution technology, combined with an ESI ion source and SIM scanning mode, to achieve accurate detection of β-aminocrotonate.
This technology enables high-precision, low-limit detection of β-aminocrotonate in dihydropyridine calcium channel blockers, ensuring that drug quality meets ICH standards and protecting patient health.
Smart Images

Figure CN122306976A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of analytical chemistry technology, and specifically relates to an analytical detection method for related substances in dihydropyridine compounds. Technical Background
[0002] Dihydropyridine calcium channel blockers are a class of drugs commonly used in clinical practice to treat hypertension. Common dihydropyridine drugs include nicardipine, felodipine, nifedipine, nifedipine, and amlodipine. Some of these are marketed as acid salts, such as amlodipine besylate, amlodipine maleate, amlodipine mesylate, amlodipine aspartate, nicardipine hydrochloride, lercanidipine hydrochloride, benidipine hydrochloride, barnidipine hydrochloride, and manidipine hydrochloride.
[0003] Most dihydropyridine calcium channel blockers are prepared from β-aminocrotonic acid esters. However, β-aminocrotonic acid esters have a structure as shown in Formula IA, which contains an unsaturated ketone structure. Compounds containing this structure are defined by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) as potentially genotoxic impurities, and their content must not exceed 12 ppm. Therefore, it is necessary to strictly control the residual amount of β-aminocrotonic acid esters in dihydropyridine calcium channel blocker products to ensure product quality and thus protect patients' health.
[0004]
[0005] Although CN115201379 discloses a gas chromatography method for the detection of ethyl β-aminocrotonate in felodipine and CN118130675 discloses a high-performance liquid chromatography method for the detection of methyl β-aminocrotonate in amlodipine besylate, a more accurate method for the detection of β-amino-α,β-unsaturated esters is still needed. Summary of the Invention
[0006] This invention provides a method for the analysis and detection of related substances in dihydropyridine compounds, characterized by comprising the following steps:
[0007] (1) Add ninhydrin to the test solution containing dihydropyridine compounds to prepare the test solution;
[0008] (2) The content of compound I in dihydropyridine compounds was determined by liquid chromatography-mass spectrometry.
[0009]
[0010] Among them, R 1 It is a C1-C2 alkyl group, R 2 It is a C1 to C6 alkyl group.
[0011] In some embodiments of the present invention, the R 1It is a methyl group.
[0012] In some embodiments of the present invention, the R 2 The R is methyl, ethyl, n-propyl, or isopropyl; in some typical embodiments of the invention, the R... 2 It is a methyl group.
[0013] In some embodiments of the present invention, the dihydropyridine compound is in the form of a free base or an acid salt; in some typical embodiments of the present invention, the dihydropyridine compound is in the form of a free base; in some more typical embodiments of the present invention, the dihydropyridine compound is nicardipine, amlodipine, lercanidipine, benidipine, barnidipine, or manidipine; in some typical embodiments of the present invention, the dihydropyridine compound is in the form of an acid salt; in some more typical embodiments of the present invention, the dihydropyridine compound is nicardipine hydrochloride, lercanidipine hydrochloride, benidipine hydrochloride, barnidipine hydrochloride, manidipine hydrochloride, amlodipine besylate, amlodipine maleate, amlodipine mesylate, or amlodipine aspartate; in some most typical embodiments of the present invention, the dihydropyridine compound is nicardipine hydrochloride.
[0014] In some embodiments of the present invention, the content of compound I in the geohydropyridine compound is less than or equal to 24 ppm.
[0015] In some embodiments of the present invention, the test solution in step (1) is prepared by mixing a solvent and a dihydropyridine compound.
[0016] In some embodiments of the present invention, the solvent of the test solution in step (1) is water, an organic solvent, or a mixture of two of them; in some typical embodiments of the present invention, the solvent of the test solution in step (1) is a mixture of water and an organic solvent, and the test solution optionally contains an alkali; in some more typical embodiments of the present invention, the solvent of the test solution in step (1) is a mixture of water and an organic solvent, and the test solution contains an alkali; in some of the most typical embodiments of the present invention, the test solution in step (1) is prepared by mixing a dihydropyridine compound, an aqueous solution of an alkali, and an organic solvent.
[0017] In some embodiments of the present invention, the alkali in the test solution in step (1) is sodium hydroxide or potassium hydroxide; in some typical embodiments of the present invention, the alkali in the test solution in step (1) is sodium hydroxide.
[0018] In some embodiments of the present invention, the organic solvent in the test solution in step (1) is methanol or acetonitrile; in some typical embodiments of the present invention, the organic solvent in the test solution in step (1) is methanol.
[0019] In some embodiments of the present invention, the concentration of the alkali in the aqueous solution of the base used to prepare the test solution in step (1) is 30-50 mmol / L, calculated as monovalent base ions; in some typical embodiments of the present invention, the concentration of the alkali in the aqueous solution of the base used to prepare the test solution in step (1) is 40 mmol / L, calculated as monovalent base ions.
[0020] In some embodiments of the present invention, the volume ratio of the aqueous solution of alkali to the organic solvent used in step (1) to prepare the test solution is 1:3-5; in some typical embodiments of the present invention, the volume ratio of the aqueous solution of alkali to the organic solvent used in step (1) to prepare the test solution is 1:3.5-4.5; in some more typical embodiments of the present invention, the volume ratio of the aqueous solution of alkali to the organic solvent used in step (1) to prepare the test solution is 1:4.
[0021] In some embodiments of the present invention, the test solution in step (1) is prepared by dissolving the dihydropyridine compound in a mixed solution containing sodium hydroxide, water and an alcohol solvent; in some typical embodiments of the present invention, the test solution in step (1) is prepared by weighing 40 mg of nicardipine hydrochloride sample, accurately weighing it into a 10 mL volumetric flask, dissolving it with a diluent and diluting it to the mark, wherein the diluent is a 40 mM sodium hydroxide aqueous solution: methanol = 20:80 (V:V).
[0022] In some embodiments of the present invention, ninhydrin is added in step (1) in solid or solution form; in some typical embodiments of the present invention, ninhydrin is added in solution form in step (1); in some more typical embodiments of the present invention, ninhydrin is added in ethanol or acetone solution form in step (1); in some of the most typical embodiments of the present invention, ninhydrin is added in ethanol solution form in step (1).
[0023] In some embodiments of the present invention, the concentration of the ninhydrin solution in step (1) is 4-10 mg / mL; in some typical embodiments of the present invention, the concentration of the ninhydrin solution in step (1) is 4-8 mg / mL; in some more typical embodiments of the present invention, the concentration of the ninhydrin solution in step (1) is 4-6 mg / mL; in some most typical embodiments of the present invention, the concentration of the ninhydrin solution in step (1) is 5 mg / mL.
[0024] In some embodiments of the present invention, the concentration of dihydropyridine compounds in the test solution in step (1) is 1-5 mg / mL; in some typical embodiments of the present invention, the concentration of dihydropyridine compounds in the test solution in step (1) is 1-4 mg / mL; in some more typical embodiments of the present invention, the concentration of dihydropyridine compounds in the test solution in step (1) is 1-3 mg / mL; in some most typical embodiments of the present invention, the concentration of dihydropyridine compounds in the test solution in step (1) is 2 mg / mL.
[0025] In some embodiments of the present invention, the liquid chromatography-mass spectrometry analysis method in step (2) has the following characteristics: the liquid chromatography-mass spectrometry analysis method uses an octadecylsilane-bonded silica gel column as a high-performance liquid chromatography column, and uses mobile phase A and mobile phase B for gradient elution; and mobile phase A is a mixed solution of trifluoroacetic acid, formic acid and water or a mixed solution of trifluoroacetic acid, acetonitrile and water, and mobile phase B is a mixed solution of trifluoroacetic acid, formic acid and acetonitrile or a mixed solution of trifluoroacetic acid and acetonitrile.
[0026] In some typical embodiments of the present invention, the liquid chromatography-mass spectrometry analysis method in step (2) has the following characteristics: the liquid chromatography-mass spectrometry analysis method uses an octadecylsilane-bonded silica gel column as a high-performance liquid chromatography column, and uses mobile phase A and mobile phase B for gradient elution; and mobile phase A is a mixed solution of trifluoroacetic acid, acetonitrile and water, and mobile phase B is a mixed solution of trifluoroacetic acid and acetonitrile.
[0027] In some more typical embodiments of the present invention, the liquid chromatography-mass spectrometry analysis method in step (2) has the following characteristics: the liquid chromatography-mass spectrometry analysis method uses an octadecylsilane-bonded silica gel column as a high-performance liquid chromatography column, and uses mobile phase A and mobile phase B for gradient elution; and mobile phase A is a mixed solution of trifluoroacetic acid, acetonitrile and water in a volume ratio of 1:50:950, and mobile phase B is a 0.1% (V / V) trifluoroacetic acid acetonitrile solution.
[0028] In some embodiments of the present invention, the gradient elution in the liquid chromatography-mass spectrometry analysis method in step (2) is as follows:
[0029]
[0030]
[0031] In some embodiments of the present invention, the flow rate of the mobile phase in the liquid chromatography-mass spectrometry analysis method in step (2) is 0.4-0.8 mL / min; in some typical embodiments of the present invention, the flow rate of the mobile phase in the liquid chromatography-mass spectrometry analysis method in step (2) is 0.4-0.6 mL / min; in some more typical embodiments of the present invention, the flow rate of the mobile phase in the liquid chromatography-mass spectrometry analysis method in step (2) is 0.5 mL / min.
[0032] In some embodiments of the present invention, the column temperature of the high-performance liquid chromatography column in step (2) of the liquid chromatography-mass spectrometry analysis method is 30-50°C; in some typical embodiments of the present invention, the column temperature of the high-performance liquid chromatography column in step (2) is 40-50°C; in some more typical embodiments of the present invention, the column temperature of the high-performance liquid chromatography column in step (2) is 42-48°C; in some most typical embodiments of the present invention, the column temperature of the high-performance liquid chromatography column in step (2) is 45°C.
[0033] In some embodiments of the present invention, the ion source of the mass spectrometer detector in the liquid chromatography-mass spectrometry analysis method in step (2) is ESI, and the scanning mode is SIM; in some typical embodiments of the present invention, the ion source of the mass spectrometer detector in the liquid chromatography-mass spectrometry analysis method in step (2) is ESI, the scanning mode is SIM, and the SIM ion current is 244 m / z.
[0034] In some embodiments of the present invention, the fragmentation capability of the mass spectrometer detector in the liquid chromatography-mass spectrometry analysis method in step (2) is 50-80V; in some typical embodiments of the present invention, the fragmentation capability of the mass spectrometer detector in the liquid chromatography-mass spectrometry analysis method in step (2) is 60-80V; in some more typical embodiments of the present invention, the fragmentation capability of the mass spectrometer detector in the liquid chromatography-mass spectrometry analysis method in step (2) is 65-75V; in some of the most typical embodiments of the present invention, the fragmentation capability of the mass spectrometer detector in the liquid chromatography-mass spectrometry analysis method in step (2) is 70V.
[0035] In some embodiments of the present invention, the mass spectrometry acquisition time in the liquid chromatography-mass spectrometry analysis method in step (2) is 1-5 min; in some typical embodiments of the present invention, the mass spectrometry acquisition time in the liquid chromatography-mass spectrometry analysis method in step (2) is 1.2-5 min; in some more typical embodiments of the present invention, the mass spectrometry acquisition time in the liquid chromatography-mass spectrometry analysis method in step (2) is 1.4-5 min; in some most typical embodiments of the present invention, the mass spectrometry acquisition time in the liquid chromatography-mass spectrometry analysis method in step (2) is 1.5-5 min.
[0036] In some embodiments of the present invention, the peak width in the total ion chromatogram of the liquid chromatography-mass spectrometry analysis method in step (2) is 0.1-0.2 min; in some typical embodiments of the present invention, the peak width in the liquid chromatography-mass spectrometry analysis method in step (2) is 0.1-0.15 min; in some more typical embodiments of the present invention, the peak width in the liquid chromatography-mass spectrometry analysis method in step (2) is 0.1-0.13 min; in some most typical embodiments of the present invention, the peak width in the liquid chromatography-mass spectrometry analysis method in step (2) is 0.1 min.
[0037] In some embodiments of the present invention, the gain value in the liquid chromatography-mass spectrometry analysis method in step (2) is 1.0.
[0038] In some embodiments of the present invention, the flow rate of the drying gas from the electro-injected ion source in step (2) of the liquid chromatography-mass spectrometry analysis method is 10-13 L / min; in some typical embodiments of the present invention, the flow rate of the drying gas from the electro-injected ion source in step (2) of the liquid chromatography-mass spectrometry analysis method is 11-13 L / min; in some more typical embodiments of the present invention, the flow rate of the drying gas from the electro-injected ion source in step (2) of the liquid chromatography-mass spectrometry analysis method is 11.5-12.5 L / min. In some of the most typical embodiments of the present invention, the flow rate of the drying gas from the electro-injected ion source in step (2) of the liquid chromatography-mass spectrometry analysis method is 12 L / min.
[0039] In some embodiments of the present invention, the drying gas temperature of the electro-injection ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 300-400°C; in some typical embodiments of the present invention, the drying gas temperature of the electro-injection ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 320-380°C; in some more typical embodiments of the present invention, the drying gas temperature of the electro-injection ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 345-365°C; in some most typical embodiments of the present invention, the drying gas temperature of the electro-injection ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 350°C.
[0040] In some embodiments of the present invention, the nebulizing gas pressure of the electro-injection ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 40-80 psi; in some typical embodiments of the present invention, the nebulizing gas pressure of the electro-injection ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 50-70 psi; in some more typical embodiments of the present invention, the nebulizing gas pressure of the electro-injection ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 55-65 psi; in some most typical embodiments of the present invention, the nebulizing gas pressure of the electro-injection ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 60 psi.
[0041] In some embodiments of the present invention, the capillary voltage of the electrospray ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 2500-3500V; in some typical embodiments of the present invention, the capillary voltage of the electrospray ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 2700-3300V; in some more typical embodiments of the present invention, the capillary voltage of the electrospray ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 2900-3100V; in some most typical embodiments of the present invention, the capillary voltage of the electrospray ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is 3000V.
[0042] In some embodiments of the present invention, the ion mode of the electrospray ion source in the liquid chromatography-mass spectrometry analysis method in step (2) is positive ion mode.
[0043] In some embodiments of the present invention, the injection volume of the liquid chromatography-mass spectrometry analysis method in step (2) is 1 μL.
[0044] In some embodiments of the present invention, the liquid chromatography-mass spectrometry analysis method in step (2) uses the following instruments and conditions:
[0045]
[0046] In some embodiments of the present invention, in the liquid chromatography-mass spectrometry analysis method of step (2), the content of compound I in the test solution is calculated in the following manner:
[0047]
[0048] in:
[0049] Cs—The concentration of the derivative corresponding to the compound of formula I in the standard solution, in ng / mL, based on the compound of formula I;
[0050] Ci—Concentration of dihydropyridine compounds in the test solution, mg / mL;
[0051] Peak area of the peaks in the total ion chromatogram obtained from the As standard solution;
[0052] Ai—The peak area of the peak with the same retention time as the peak of the standard solution in the total ion chromatogram of the test solution;
[0053] The standard solution refers to the solution obtained by mixing a solution of compound I with a known accurate concentration with a solution of ninhydrin, and the molar ratio of ninhydrin to compound I is >1.
[0054] In some embodiments of the present invention, in the liquid chromatography-mass spectrometry analysis method of step (2), As is the peak area of the peak obtained in the total ion chromatogram of 1 injection of standard solution, or the average peak area of the peak obtained in the total ion chromatogram of 2-10 injections of standard solution; in some typical embodiments of the present invention, in the liquid chromatography-mass spectrometry analysis method of step (2), As is the average peak area of the peak obtained in the total ion chromatogram of 4-8 injections of standard solution; in some more typical embodiments of the present invention, in the liquid chromatography-mass spectrometry analysis method of step (2), As is the average peak area of the peak obtained in the total ion chromatogram of 6 injections of standard solution.
[0055] In some embodiments of the present invention, the standard solution in the liquid chromatography-mass spectrometry analysis method of step (2) is prepared using a stock solution, wherein the stock solution is prepared by dissolving β-aminocrotonic acid ester in a mixed solution containing sodium hydroxide, water, and an alcohol solvent; in some typical embodiments of the present invention, the standard solution in step (2) is prepared using a stock solution, wherein the stock solution is prepared by dissolving β-aminocrotonic acid ester in an alcohol solvent and then mixing it with a mixed solution containing sodium hydroxide, water, and an alcohol solvent; in some more typical embodiments of the present invention, the standard solution in step (2) is prepared using a stock solution, wherein the stock solution is prepared by weighing 50 mg of β-aminocrotonic acid ester, accurately weighing it into a 50 mL volumetric flask, dissolving and diluting it to the mark with methanol, mixing well, then accurately transferring 1.0 mL of the solution into a 10 mL volumetric flask, diluting it to the mark with methanol, mixing well, then accurately transferring 6.0 mL of the solution into a 10 mL volumetric flask. In a 100 mL volumetric flask, dilute to the mark with methanol, mix well, and then accurately transfer 8.0 mL of the solution to a 100 mL volumetric flask. Dilute to the mark with diluent, mix well, wherein the diluent is a 40 mM sodium hydroxide aqueous solution: methanol = 20:80 (V:V); In some of the most typical embodiments of the present invention, the standard solution in step (2) is prepared using a stock solution, wherein the stock solution is prepared by weighing 50 mg of methyl β-aminocrotonate, accurately weighing... Dissolve and dilute to the mark with methanol in a 50 mL volumetric flask, mix well, then accurately transfer 1.0 mL of the solution to a 10 mL volumetric flask, dilute to the mark with methanol, mix well, then accurately transfer 6.0 mL of the solution to a 100 mL volumetric flask, dilute to the mark with methanol, mix well, then accurately transfer 8.0 mL of the solution to a 100 mL volumetric flask, dilute to the mark with diluent, mix well, wherein the diluent is 40 mM sodium hydroxide aqueous solution: methanol = 20:80 (V:V).
[0056] In some embodiments of the present invention, the standard solution in the liquid chromatography-mass spectrometry analysis method in step (2) is prepared by mixing the stock solution with a mixed solution containing sodium hydroxide, water and an alcohol solvent, and then mixing it with ninhydrin; in some typical embodiments of the present invention, the standard solution is prepared by accurately transferring 1.0 mL of the stock solution into a 10 mL volumetric flask, diluting it to the mark with a diluent, mixing it well, and then accurately transferring 0.5 mL of the aforementioned solution and 0.5 mL of the ninhydrin solution into a 1.5 mL liquid chromatography vial, mixing it thoroughly, wherein the diluent is a 40 mM sodium hydroxide aqueous solution: methanol = 20:80 (V:V).
[0057] The detection method provided by this invention has the characteristics of good precision, high accuracy, high sensitivity, good linearity, good stability of the test solution, low detection limit, and accurate detection results.
[0058] In this invention, ninhydrin undergoes a derivatization reaction with the compound of formula I in a 1:1 molar ratio. That is, in step (1), when the molar amount of ninhydrin is greater than or equal to the molar amount of the compound of formula I in the solution mixed with it, the content of the compound of formula I can be accurately detected, and the excess ninhydrin added has no effect on the analytical method. It is worth noting that those skilled in the art can and easily adjust the amount of ninhydrin added according to the detection target, including but not limited to, in order to quantitatively analyze the content of the compound of formula I in dihydropyridine compounds, making the molar amount of ninhydrin in step (1) greater than or equal to the molar amount of the compound of formula I in the solution mixed with it, usually choosing greater than; or, in order to qualitatively confirm whether the compound of formula I in dihydropyridine compounds exceeds the limit of 12 ppm, using conventional conversion methods in the art, adding an amount of ninhydrin sufficient to detect 12 ppm of the compound of formula I in dihydropyridine compounds; or simply to qualitatively confirm the presence of the compound of formula I in dihydropyridine compounds, adding an appropriate amount of ninhydrin.
[0059] Unless otherwise specified, the terminology used in this invention has the following meanings:
[0060] “Dwell” refers to the duration of stay;
[0061] "EI" refers to an electro-ionization source;
[0062] "ESI" refers to electrospray ionization;
[0063] "LOD" refers to the limit of detection;
[0064] "LOQ" refers to the limit of quantitation;
[0065] "LC-MS" refers to liquid chromatography-mass spectrometry, also known as liquid chromatography-mass spectrometry detection method;
[0066] "MS" refers to mass spectrometry;
[0067] “mM” refers to mmol / L;
[0068] "ppm" refers to parts per million;
[0069] "RSD" refers to the relative standard deviation.
[0070] “SIM” refers to Selective Ion Monitoring;
[0071] "Chromatographic column refers to high performance liquid chromatography column;"
[0072] "Ninhydrin" refers to
[0073] "Nicardipine hydrochloride" refers to
[0074] "Lercadipine hydrochloride" refers to
[0075] "Benidipine hydrochloride" refers to
[0076] "Barnidipine hydrochloride" refers to
[0077] "Manidipine hydrochloride" refers to "Amlodipine besylate" refers to
[0078] "Amlodipine maleate" refers to
[0079] "Amlodipine mesylate" refers to
[0080] "Amlodipine aspartate" refers to
[0081] "The concentration of the derivative corresponding to the compound of formula I in the standard solution" refers to the mass concentration of the product obtained after the derivatization reaction of the compound of formula I with ninhydrin in the standard solution, expressed as the mass concentration of the compound of formula I. The calculation method is to divide the mass of the compound of formula I added to the standard solution by the volume of the standard solution. The rest is prepared using the relevant solutions with added ninhydrin in the same way.
[0082] "Dihydropyridine compounds" refers to a class of compounds with a dihydropyridine structure, which are commonly used as antihypertensive drugs. In this invention, the dihydropyridine compounds optionally contain related substances.
[0083] "The content of Formula I compound in geohydropyridine compounds" refers to the proportion of the mass of Formula I compound, which is an impurity that is randomly present in geohydropyridine compounds, to the total mass of geohydropyridine compounds.
[0084] A "sample" refers to a small, representative sample drawn from a population for testing and analysis.
[0085] "Test solution" refers to the solution obtained by dissolving and / or diluting the sample with a solvent;
[0086] "Test solution" refers to the solution used for experimental testing in the process of chemical analysis. It is a solution obtained by properly treating and preparing the sample to be tested.
[0087] "Standard solution" refers to a solution with a known and accurate concentration. In this invention, it refers to a solution obtained by mixing a solution with a known and accurate content of compound I with a sufficient amount of ninhydrin, wherein the concentration of the derivatized product corresponding to compound I is known and accurate.
[0088] "Diluent" refers to a liquid used to reduce the concentration of solute in the original solution.
[0089] In this invention, "same retention time" includes retention times that are completely identical or within a reasonable error range as considered by those skilled in the art.
[0090] In this invention, the molecular structure of the derivative corresponding to the compound of formula I in the standard solution or test sample solution, as shown in II-1, is a response signal in a liquid chromatography-mass spectrometry detector.
[0091]
[0092] Among them, R 2 It is a C1-C6 alkyl group. When the compound of formula I is methyl β-aminocrotonate, the molecular structure of the derivative corresponding to the compound of formula I in the standard solution or test solution is shown in the liquid chromatography-mass spectrometry detection instrument as shown in II-1-A:
[0093] Attached Figure Description
[0094] Appendix Figure 1 Total ion chromatogram of blank solution.
[0095] Appendix Figure 2 Total ion chromatogram of LOD solution.
[0096] Appendix Figure 3 Total ion chromatogram of LOQ-1 solution.
[0097] Appendix Figure 4 Total ion chromatogram of standard solutions.
[0098] Appendix Figure 5 Mass bar graph of standard solution.
[0099] Appendix Figure 6 Total ion chromatogram of the recovered solution R1.
[0100] Appendix Figure 7 Total ion chromatogram of the first batch of samples tested. Detailed Implementation
[0101] The present invention will be further illustrated by specific embodiments below, but these are not intended to limit the scope of protection of the present invention. Any modifications or alterations made to the present invention that are easily achievable by those skilled in the art without departing from the concept of the present invention will fall within the scope of the present invention. The reagents, solvents, etc. used in the present invention are all commercially available chemically pure or analytically pure products.
[0102] Example 1. Determination method of β-aminocrotonate methyl ester content in nicardipine hydrochloride
[0103] 1. Solution preparation
[0104] Diluent: 40mM sodium hydroxide aqueous solution: methanol = 20:80 (% V / V)
[0105] Ninhydrin solution: Weigh 125 mg of ninhydrin into a 25 mL volumetric flask, dissolve in ethanol, and dilute to the mark. Mix well. (The concentration of ninhydrin is 5.0 mg / mL)
[0106] Blank solution: Accurately transfer 500 μL of diluent and 500 μL of ninhydrin solution into a 1.5 mL liquid chromatography vial and mix thoroughly.
[0107] Stock solution: Accurately weigh 50 mg of methyl β-aminocrotonate into a 50 mL volumetric flask, dissolve and dilute to the mark with methanol, and mix well. Accurately transfer 1.0 mL of this solution to a 10 mL volumetric flask, dilute to the mark with methanol, and mix well. Accurately transfer 6.0 mL of this solution to a 100 mL volumetric flask, dilute to the mark with methanol, and mix well. Accurately transfer 8.0 mL of this solution to a 100 mL volumetric flask, dilute to the mark with diluent, and mix well. This is the stock solution. (Concentration: 480 ng / mL)
[0108] LOD solution: Accurately transfer 1.0 mL of the stock solution to a 100 mL volumetric flask, dilute to the mark with diluent, and mix well; then accurately transfer 0.5 mL of the above solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial, and mix thoroughly. (Based on methyl β-aminocrotonate, the corresponding derivative concentration in the LOD solution is 2.4 ng / mL.)
[0109] LOQ solution: Accurately transfer 3.0 mL of the stock solution to a 100 mL volumetric flask, dilute to the mark with diluent, and mix well; then accurately transfer 0.5 mL of the above solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial, and mix thoroughly. (The concentration of the derivative corresponding to methyl β-aminocrotonate in the LOQ solution is 7.2 ng / mL.)
[0110] Standard solution: Accurately transfer 1.0 mL of the stock solution to a 10 mL volumetric flask, dilute to the mark with diluent, and mix well; then accurately transfer 0.5 mL of the above solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial, and mix thoroughly. (The concentration of the corresponding derivative in the standard solution is 24 ng / mL, calculated as methyl β-aminocrotonate.)
[0111] Linear solution L1: Accurately transfer 1.0 mL of the stock solution to a 20 mL volumetric flask, dilute to the mark with diluent, and mix well; then accurately transfer 0.5 mL of the above solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial, and mix thoroughly. (The concentration of the derivative corresponding to methyl β-aminocrotonate in the linear solution is 12 ng / mL.)
[0112] Linear solution L2: Accurately transfer 4.0 mL of the stock solution to a 50 mL volumetric flask, dilute to the mark with diluent, and mix well; then accurately transfer 0.5 mL of the above solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial, and mix thoroughly. (Based on methyl β-aminocrotonate, the concentration of its corresponding derivative in the linear solution is 19.2 ng / mL)
[0113] Linear solution L3: Accurately transfer 1.0 mL of the stock solution to a 10 mL volumetric flask, dilute to the mark with diluent, and mix well; then accurately transfer 0.5 mL of the above solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial, and mix thoroughly. (The concentration of the derivative corresponding to methyl β-aminocrotonate in the linear solution is 24 ng / mL.)
[0114] Linear solution L4: Accurately transfer 6.0 mL of the stock solution to a 50 mL volumetric flask, dilute to the mark with diluent, and mix well; then accurately transfer 0.5 mL of the above solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial, and mix thoroughly. (The concentration of the derivative corresponding to methyl β-aminocrotonate in the linear solution is 28.8 ng / mL.)
[0115] Linear solution L5: Accurately transfer 3.0 mL of the stock solution to a 20 mL volumetric flask, dilute to the mark with diluent, and mix well; then accurately transfer 0.5 mL of the above solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial, and mix thoroughly. (The concentration of the derivative corresponding to methyl β-aminocrotonate in the linear solution is 36 ng / mL.)
[0116] Linear solution L6: Accurately transfer 2.0 mL of the stock solution to a 10 mL volumetric flask, dilute to the mark with diluent, and mix well; then accurately transfer 0.5 mL of the above solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial, and mix thoroughly. (The concentration of the derivative corresponding to methyl β-aminocrotonate in the linear solution is 48 ng / mL.)
[0117] Test solution: Weigh 40 mg of nicardipine hydrochloride sample accurately into a 10 mL volumetric flask, dissolve and dilute to the mark with diluent, mix well to obtain the test solution; then accurately transfer 0.5 mL of the test solution and 0.5 mL of ninhydrin solution into a 1.5 mL liquid chromatography vial, mix thoroughly to prepare the test solution. Prepare two parallel aliquots. (The concentration of nicardipine hydrochloride sample in the test solution is 2.0 mg / mL)
[0118] Recovery solution: Accurately weigh 40 mg of nicardipine hydrochloride sample into a 10 mL volumetric flask, dissolve it with approximately 5 mL of diluent, then accurately transfer 1.0 mL of the stock solution to the same 10 mL volumetric flask, dilute to the mark with diluent, and mix well. Then accurately transfer 0.5 mL of the above solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial, and mix thoroughly. Prepare two parallel aliquots. (The concentration of nicardipine hydrochloride is 2.0 mg / mL; the concentration of its corresponding derivative in the recovery solution, calculated as methyl β-aminocrotonate, is 24 ng / mL.)
[0119] Program-controlled solution: Prepared in the same way as standard solution.
[0120] 2. Instruments and Conditions
[0121] Table 1. Instruments and Conditions
[0122]
[0123]
[0124] 3. Calculation formula
[0125]
[0126] Wherein: Cs—the concentration of the derivative corresponding to methyl β-aminocrotonate in the standard solution, in ng / mL;
[0127] Ci—The concentration of nicardipine hydrochloride in the test solution, in mg / mL;
[0128] The average peak area of the peaks in the total ion chromatogram obtained from the As-6 needle standard solution.
[0129] Ai—The peak area of the peak with the same retention time as the peak in the total ion chromatogram of the test solution as the peak in the standard solution.
[0130] Standard: The content of methyl β-aminocrotonate is ≤12ppm.
[0131] 4. Method Validation
[0132] 4.1 Blank solution
[0133] The blank solution was analyzed under the above conditions, and the total ion chromatogram was recorded (see attached figure). Figure 1 .
[0134] Standard: In the obtained chromatogram, there should be no significant interference between the main peak and impurities (the peak area should not exceed that of the main peak and impurities in the LOD solution).
[0135] 4.2 Limit of Detection and Limit of Quantification
[0136] Under the above conditions, LOD and LOQ solutions were analyzed, with one injection of LOD solution and three injections of LOQ solution (LOQ-1 to LOQ-3). The total ion chromatogram of the LOD solution is attached. Figure 2 The total ion chromatogram of the LOQ-1 solution is attached. Figure 3 .
[0137] Standard: LOD solution: In the obtained chromatogram, the signal-to-noise ratio (S / N) of the main peak and impurities shall not be less than 3.
[0138] LOQ solution: In the obtained chromatogram, the signal-to-noise ratio (S / N) of the main peak and impurities shall not be less than 10.
[0139] Table 2. Limit of Detection and Limit of Quantification Data
[0140]
[0141] 4.3 Standard solutions, programmed control solutions, and solution stability tests
[0142] Under the above conditions, the standard solutions and programmable control solutions were analyzed. Six standard solutions were injected sequentially (STD1–STD6 after preparation), and two programmable control solutions were injected (CONTROL-1 and CONTROL-2). The total ion chromatogram and mass bar graph of the standard solutions are shown in the appendix. Figure 4 , 5 The programmed control solution refers to the solution obtained by placing the standard solution in an experimental environment for a certain period of time. Specifically, CONTRAOL-1 is the solution obtained by placing the standard solution at 25°C and 40-60% RH for 5 hours, and CONTRAOL-2 is the solution obtained by placing the standard solution at 25°C and 40-60% RH for 7 hours.
[0143] Standard: The RSD of the total ion chromatogram obtained from the 6-needle impurity standard solution is ≤5.0% by area; the RSD of the total ion chromatogram obtained from all standard solutions and program control solutions is ≤7.5% by area.
[0144] Table 3. Detection data for standard solutions and programmed control solutions
[0145]
[0146] 4.4 Linear
[0147] The linear solutions L1 to L6 were analyzed under the above conditions.
[0148] Table 4. Linear Test Data Table
[0149]
[0150] Standard: Correlation coefficient > 0.995
[0151] 4.5 recovery rate
[0152] Under the above conditions, two sets of test solutions (S1, S2) and recovery solutions (R1, R2) prepared in parallel were analyzed. The total ion chromatogram of the recovery solution R1 is attached. Figure 6 .
[0153] Recovery rate calculation formula:
[0154]
[0155] Where: A—the peak area of the peak with the same retention time as the peak emanating from the above standard solution after injection in the total ion chromatogram obtained from the recovered solution;
[0156] A S —The peak area of the peak with the same retention time as the peak eluted after the injection of the above standard solution in the total ion chromatogram of the test sample solution;
[0157] A R —The average peak area of the peaks eluted in the total ion chromatogram obtained from the 6 standard solutions;
[0158] m — the mass (mg) of nicardipine hydrochloride in the recovered solution;
[0159] m S —The mass (mg) of nicardipine hydrochloride in the test solution.
[0160] Table 5. Recovery Rate Test Data
[0161]
[0162] 5. Sample testing
[0163] Three batches of nicardipine hydrochloride samples were tested using this method, and the results are shown in the table below. The total ion chromatogram for the first test of the first batch of samples is attached. Figure 7 .
[0164] Table 6. Detection data of nicardipine hydrochloride samples
[0165]
[0166] Comparative Example 1. Detection of β-aminocrotonate methyl ester content in nicardipine hydrochloride
[0167] 1. Solution preparation
[0168] Diluent: Dimethyl sulfoxide
[0169] Blank solution: diluent
[0170] Reference stock solution: Accurately weigh 18.75 mg of methyl β-aminocrotonic acid into a 10 mL volumetric flask, dilute to the mark with diluent, and mix well; accurately transfer 1 mL of the above solution into a 10 mL volumetric flask, dilute to the mark with diluent, and mix well. (The concentration of methyl β-aminocrotonic acid is 187.5 μg / mL)
[0171] Reference solution: Accurately transfer 1 mL of the reference solution to a 100 mL volumetric flask, dilute to the mark with diluent, and mix well. Transfer 1 mL of the above solution to a 2 mL vial, and seal tightly. (The concentration of methyl β-aminocrotonate is 1875 ng / mL)
[0172] Test solution: Weigh 0.01 g of nicardipine hydrochloride sample accurately into a 2 mL vial, accurately transfer 1 mL of diluent, cap and seal, and mix well. Prepare two parallel solutions. (The concentration of nicardipine hydrochloride in the test solution is 10 mg / mL.)
[0173] Recovery solution for the test sample: Weigh 0.01 g of nicardipine hydrochloride sample accurately into a 2 mL vial, accurately transfer 1 mL of the reference solution, cap and seal, and mix well. Prepare two parallel aliquots. (The concentration of nicardipine hydrochloride sample is 10 mg / mL; the content of methyl β-aminocrotonate is 1875 ng / mL)
[0174] 2. Chromatographic conditions
[0175] Table 7. Gas Chromatography Conditions for Detection
[0176]
[0177] 3. Calculation formula
[0178]
[0179] Wherein: Cd—the concentration (μg / mL) of methyl β-aminocrotonate in the reference solution;
[0180] Cu—Concentration of nicardipine hydrochloride in the test solution (mg / mL);
[0181] Ru—The peak area of the peak with the same retention time as the peak eluted after the injection of the reference solution in the total ion chromatogram of the test solution;
[0182] Rs—The average peak area of the peaks appearing in the total ion chromatogram obtained from the reference solution.
[0183] 4. Method Validation
[0184] 4.1 Recovery rate
[0185] The reference solution, two sets of test solutions (S3, S4) prepared in parallel, and the test sample recovery solutions (R3, R4) were analyzed according to this method; the reference solution was injected 5 times (STD7 to STD11, and the injections were started sequentially after the solution was prepared).
[0186] Recovery rate calculation formula:
[0187]
[0188] Where: R—the peak area of the peak with the same retention time as the peak emanating from the above reference solution after injection in the total ion chromatogram obtained from the recovered ion chromatogram of the test sample;
[0189] C—Concentration of the test sample in the recovered solution (mg / mL);
[0190] Cu—Concentration of the test sample in the test sample solution (mg / mL);
[0191] Ru—The peak area of the peak with the same retention time as the peak eluted after the injection of the reference solution in the total ion chromatogram of the test solution;
[0192] Rs—The average peak area of the peaks appearing in the total ion chromatogram obtained from the reference solution.
[0193] Table 8. Detection data of reference solution
[0194]
[0195] Table 9. Recovery Rate Test Data
[0196] project Weigh (mg) Concentration (mg / mL) Peak area Recovery rate % S3 10.21 10.21 0.00 / S4 10.72 10.72 0.00 / R3 10.24 10.24 11494 82.63 R4 10.69 10.69 11380 81.81
Claims
1. A method for analyzing and detecting related substances in dihydropyridine compounds, characterized in that... Includes the following steps: (1) Add ninhydrin to the test solution containing dihydropyridine compounds to prepare the test solution; (2) The content of compound I in dihydropyridine compounds was determined by liquid chromatography-mass spectrometry. Among them, R 1 It is a C1-C2 alkyl group, R 2 It is a C1 to C6 alkyl group.
2. The analytical detection method according to claim 1, wherein R 1 The R is methyl; 2 The compound is methyl, ethyl, n-propyl, or isopropyl, preferably methyl; the dihydropyridine compound is in the form of a free base or an acid salt, preferably in the form of a free base, more preferably nicardipine, amlodipine, lorcanidipine, benidipine, barnidipine, or manidipine, preferably in the form of an acid salt, more preferably nicardipine hydrochloride, lorcanidipine hydrochloride, benidipine hydrochloride, barnidipine hydrochloride, manidipine hydrochloride, amlodipine besylate, amlodipine maleate, amlodipine mesylate, or amlodipine aspartate, and most preferably nicardipine hydrochloride.
3. The analytical detection method according to claim 1 or 2, wherein the test solution in step (1) is prepared by mixing a solvent and a dihydropyridine compound; the solvent of the test solution in step (1) is one or a mixture of two of water and organic solvents, preferably a mixture of water and organic solvents, and optionally contains an alkali, more preferably a mixture of water and organic solvents, and the test solution contains an alkali, most preferably prepared by mixing a dihydropyridine compound, an aqueous solution of an alkali, and an organic solvent; the alkali in the test solution in step (1) is sodium hydroxide or potassium hydroxide, preferably sodium hydroxide; the organic solvent in the test solution in step (1) is methanol or acetonitrile, preferably methanol; In step (1), the alkali in the aqueous solution used to prepare the test solution is calculated as monovalent alkali ions, and the concentration of the alkali is 30-50 mmol / L, preferably 40 mmol / L; the volume ratio of the aqueous solution of alkali to the organic solvent in step (1) is 1:3-5, preferably 1:3.5-4.5, more preferably 1:4; the test solution in step (1) is prepared by dissolving the dihydropyridine compound in a mixed solution containing sodium hydroxide, water and alcohol solvent, preferably by weighing 40 mg of nicardipine hydrochloride sample, accurately weighing it into a 10 mL volumetric flask, dissolving it with a diluent and diluting it to the mark, wherein the diluent is 40 mM sodium hydroxide aqueous solution: methanol = 20:80 (V:V).
4. The analytical detection method according to any one of claims 1-3, wherein in step (1), ninhydrin is added in solid form or solution form, preferably in solution form, more preferably in ethanol or acetone solution form, and most preferably in ethanol solution form; the concentration of ninhydrin solution in step (1) is 4-10 mg / mL, preferably 4-8 mg / mL, more preferably 4-6 mg / mL, and most preferably 5 mg / mL.
5. The analytical detection method according to any one of claims 1-4, wherein the concentration of dihydropyridine compounds in the test solution in step (1) is 1-5 mg / mL, preferably 1-4 mg / mL, more preferably 1-3 mg / mL, and most preferably 2 mg / mL.
6. The analytical detection method according to any one of claims 1-5, wherein the liquid chromatography-mass spectrometry analysis method in step (2) has the following characteristics: the liquid chromatography-mass spectrometry analysis method uses an octadecylsilane-bonded silica gel column as a high-performance liquid chromatography column, and uses mobile phase A and mobile phase B for gradient elution, wherein mobile phase A is a mixed solution of trifluoroacetic acid, formic acid and water or a mixed solution of trifluoroacetic acid, acetonitrile and water, and mobile phase B is a mixed solution of trifluoroacetic acid, formic acid and acetonitrile or a mixed solution of trifluoroacetic acid and acetonitrile, preferably, mobile phase A is a mixed solution of trifluoroacetic acid, acetonitrile and water. The solution, mobile phase B is a mixed solution of trifluoroacetic acid and acetonitrile, more preferably, mobile phase A is a mixed solution of trifluoroacetic acid, acetonitrile and water in a volume ratio of 1:50:950, and mobile phase B is a 0.1% (v / v) trifluoroacetic acid acetonitrile solution; the flow rate of the mobile phase in the liquid chromatography-mass spectrometry analysis method is 0.4-0.8 mL / min, preferably 0.4-0.6 mL / min, more preferably 0.5 mL / min; the column temperature of the high-performance liquid chromatography column in the liquid chromatography-mass spectrometry analysis method is 30-50℃, preferably 40-50℃, more preferably... The optimal temperature range is 42-48℃, with 45℃ being the most preferred. In the liquid chromatography-mass spectrometry (LC-MS) method, the ion source of the mass spectrometer is ESI, and the scanning mode is SIM. Preferably, the ion source is ESI, the scanning mode is SIM, and the SIM ion current is 244 m / z. The fragmentation capability of the mass spectrometer in the LC-MS method is 50-80V, preferably 60-80V, more preferably 65-75V, and most preferably 70V. The mass spectrometry acquisition time in the LC-MS method is 1-5 min, preferably 1.2-5 min, more preferably... Preferably, the time interval is 1.4-5 min, most preferably, it is 1.5-5 min; the peak width in the total ion chromatogram of the liquid chromatography-mass spectrometry analysis method is 0.1-0.2 min, preferably, it is 0.1-0.15 min, more preferably, it is 0.1-0.13 min, and most preferably, it is 0.1 min; the gain value of the liquid chromatography-mass spectrometry analysis method is 1.0; the dry gas flow rate of the electrospray ion source in the liquid chromatography-mass spectrometry analysis method is 10-13 L / min, preferably, it is 11-13 L / min, and more preferably, it is 11.5-12 L / min.The flow rate is 5 L / min, most preferably 12 L / min; the drying gas temperature of the electro-injection ion source in the liquid chromatography-mass spectrometry (LC-MS) method is 300-400℃, preferably 320-380℃, more preferably 345-365℃, and most preferably 350℃; the nebulizing gas pressure of the electro-injection ion source in the LC-MS method is 40-80 psi, preferably 50-70 psi, more preferably 55-65 psi, and most preferably 60 psi; the capillary voltage of the electro-injection ion source in the LC-MS method is 2500-3500 V, preferably 2700-3300 V, more preferably 2900-3100 V, and most preferably 3000 V; the ion mode of the electro-injection ion source in the LC-MS method is positive ion mode. The injection volume of the liquid chromatography-mass spectrometry (LC-MS) method is 1 μL; the gradient elution in the LC-MS method is as follows:
7. The analytical detection method according to any one of claims 1-6, wherein the liquid chromatography-mass spectrometry analysis method employs the following instruments and conditions:
8. The analytical detection method according to any one of claims 1-7, wherein the content of compound I in the test solution is calculated by the following method: in: Cs—The concentration of the derivative corresponding to the compound of formula I in the standard solution, in ng / mL, based on the compound of formula I; Ci—Concentration of dihydropyridine compounds in the test solution, mg / mL; Peak area of the peaks in the total ion chromatogram obtained from the As standard solution; Ai—The peak area of the peak with the same retention time as the peak of the standard solution in the total ion chromatogram of the test solution; The standard solution refers to the solution obtained by mixing a solution of compound I with a known accurate concentration with a solution of ninhydrin, and the molar ratio of ninhydrin to compound I is >1.
9. The analytical detection method according to any one of claims 1-8, wherein in the liquid chromatography-mass spectrometry analysis method, the standard solution is prepared using a stock solution, wherein the stock solution is prepared by dissolving β-aminocrotonic acid ester in a mixed solution containing sodium hydroxide, water, and an alcohol solvent; preferably, β-aminocrotonic acid ester is dissolved in an alcohol solvent and then mixed with the mixed solution containing sodium hydroxide, water, and an alcohol solvent; more preferably, 50 mg of β-aminocrotonic acid ester is accurately weighed into a 50 mL volumetric volume. In a volumetric flask, dissolve and dilute to the mark with methanol, mix well, then accurately transfer 1.0 mL of this solution to a 10 mL volumetric flask, dilute to the mark with methanol, mix well, then accurately transfer 6.0 mL of this solution to a 100 mL volumetric flask, dilute to the mark with methanol, mix well, then accurately transfer 8.0 mL of this solution to a 100 mL volumetric flask, dilute to the mark with diluent, mix well. The diluent is a 40 mM sodium hydroxide aqueous solution: methanol = 20:80 (V:V), most preferably, 50 mg of β-ammonia... Methyl tribazoate was accurately weighed into a 50 mL volumetric flask, dissolved and diluted to the mark with methanol, and mixed well. Then, 1.0 mL of this solution was accurately transferred to a 10 mL volumetric flask, diluted to the mark with methanol, and mixed well. Next, 6.0 mL of this solution was accurately transferred to a 100 mL volumetric flask, diluted to the mark with methanol, and mixed well. Finally, 8.0 mL of this solution was accurately transferred to a 100 mL volumetric flask, diluted to the mark with a diluent (40 mM sodium hydroxide aqueous solution: methanol = 20:80, V:V) and mixed well. The standard solution in the liquid chromatography-mass spectrometry analysis method is prepared by mixing the stock solution with a mixed solution containing sodium hydroxide, water and an alcohol solvent, and then mixing it with ninhydrin. Preferably, to accurately transfer 1.0 mL of the stock solution to a 10 mL volumetric flask, dilute to the mark with diluent, mix well, and then accurately transfer 0.5 mL of the aforementioned solution and 0.5 mL of ninhydrin solution to a 1.5 mL liquid chromatography vial and mix thoroughly, wherein the diluent is a 40 mM sodium hydroxide aqueous solution: methanol = 20:80 (V:V).
